Clinicopathological, immunohistochemical and molecular features of acinic cell carcinoma of the breast
- PMID: 38304172
- PMCID: PMC10831401
- DOI: 10.3892/ol.2024.14241
Clinicopathological, immunohistochemical and molecular features of acinic cell carcinoma of the breast
Abstract
Breast acinic cell carcinoma (ACC) is a rare subtype of breast cancer. Accurate diagnosis of ACC using core needle biopsy (CNB) is pivotal for the use of effective treatments and patient prognosis. In the present study, a detailed analysis of the morphological, immunohistochemical and gene mutation features of 2 cases of ACC was performed. CNB was performed prior to surgical excision. The breast ACC in the present cases exhibited overt burrowing labyrinthine networks or 'hand-holding-hand' features. The tumor cells in both of the present cases expressed cytokeratin (CK)7, S100 and CK5/6, but were negative for p63, estrogen receptor and progesterone receptor. GATA binding protein 3 was positive in case 1 but negative in case 2. Fluorescence in situ hybridization indicated no ETS variant transcription factor 6 break-apart probe detection. Next-generation sequencing results revealed the same mutation and a similar abundance in exon 27 (NM_005120.2; c.3817G>T; p.A1273S) of the mediator of RNA polymerase II transcription, subunit 12 homolog (MED12) gene in both patients. To conclude, the findings of the present study suggested that recognition of this rare 'hand-holding-hand' structure could potentially be beneficial for avoiding patient misdiagnosis. In addition, it could be suggested that a mutation in the MED12 exon 27 was associated with the formation of a burrowing labyrinthine network or 'hand-holding-hand' feature.
Keywords: acinic cell carcinoma; breast cancer; mediator of RNA polymerase II transcription; subunit 12 homolog.
Copyright: © Yang et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
Primary acinic cell carcinoma of the breast: A case report with a clinicopathological and immunohistochemical study of a rare breast cancer subtype.Ann Med Surg (Lond). 2018 Sep 27;35:137-140. doi: 10.1016/j.amsu.2018.09.030. eCollection 2018 Nov. Ann Med Surg (Lond). 2018. PMID: 30305896 Free PMC article.
-
Acinic Cell Carcinoma of the Breast: Report of a Case With Immunohistochemical and Next-Generation Sequencing Studies.Int J Surg Pathol. 2021 Dec;29(8):882-886. doi: 10.1177/10668969211008508. Epub 2021 Apr 7. Int J Surg Pathol. 2021. PMID: 33827325
-
First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report.BMC Cancer. 2013 Feb 1;13:46. doi: 10.1186/1471-2407-13-46. BMC Cancer. 2013. PMID: 23374397 Free PMC article.
-
Acinic cell carcinoma of the breast: review of the literature.Int J Surg. 2014;12 Suppl 1:S35-9. doi: 10.1016/j.ijsu.2014.05.004. Epub 2014 May 22. Int J Surg. 2014. PMID: 24859406 Review.
-
Acinic cell carcinoma of the breast: A comprehensive review.Breast. 2022 Dec;66:208-216. doi: 10.1016/j.breast.2022.10.012. Epub 2022 Oct 28. Breast. 2022. PMID: 36332545 Free PMC article. Review.
Cited by
-
New insights into acinic cell carcinoma of the breast: clinicopathology, origin of histology, molecular features, prognosis, and treatment.Front Oncol. 2024 Sep 2;14:1438179. doi: 10.3389/fonc.2024.1438179. eCollection 2024. Front Oncol. 2024. PMID: 39286022 Free PMC article. Review.
-
Elucidating the nature of acinic cell carcinoma of the breast with high-grade morphology: evidence from case report.Diagn Pathol. 2024 Jul 24;19(1):100. doi: 10.1186/s13000-024-01521-1. Diagn Pathol. 2024. PMID: 39049123 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials